SII and SIRI as Prognostic Biomarkers in Lupus Nephritis
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Clinical Trials Related to Lupus Nephritis
Related studies linked through entity extraction aliases.
A Prospective, Multicenter Trial to Explore the Efficacy and Safety of Obinutuzumab Adds on to Standard-of-care Therapy Consisting of Mycophenolate Mofetil (MMF) and Corticosteroids (O-triple) as Initial Therapy in the Active Lupus Nephritis Patients
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Assessing Residual Inflammation and Macrophage Presence in Lupus Nephritis After 3 Months of Intensified Treatment With Prednisolone, Mycofenolate Mofetil and Voclosporin as Compared to Mycofenolate Mofetil and Prednisolone
- Status
- RECRUITING
- Phase
- PHASE4
Obinutuzumab for Systemic Lupus Erythematosus Pure Membranous Nephropathy: a Phase II Trial
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Rituximab Combining With Low-Dose Mycophenolate Mofetil on Proliferative Lupus Nephritis in Children
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Biomarker Development for Autoimmune Disorders Involving the Kidneys
- Status
- RECRUITING
- Phase
- N/A
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
- Status
- RECRUITING
- Phase
- PHASE4
A Study to Evaluate Mosunetuzumab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis
- Status
- RECRUITING
- Phase
- PHASE2
A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
- Status
- RECRUITING
- Phase
- PHASE2
SELECT-SLE: Biomarker-Guided CAR-T Target Selection for Refractory Lupus
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
CHT105 for the Treatment of Refractory Lupus Nephritis
- Status
- ENROLLING_BY_INVITATION
- Phase
- NA
Anti-alpha-actinin Antibodies and Lupus Nephritis Activity
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Therapeutic Drug Monitoring of Mycophenolate Mofetil in Lupus Nephritis
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A Multicenter Phase 2a Clinical Study to Evaluate SIM0278 in Subjects With Active Lupus Nephritis
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Efficacy and Safety of CRC01 in Participants With Severe, Refractory Systemic Lupus Erythematosus
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial
- Status
- RECRUITING
- Phase
- PHASE4
UB-VV410 in Subjects With Active Refractory Systemic Lupus Erythematosus or Lupus Nephritis
- Status
- RECRUITING
- Phase
- PHASE1
LUPKYNIS Drug-use Results Survey
- Status
- RECRUITING
- Phase
- N/A
Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)
- Status
- RECRUITING
- Phase
- PHASE2
Evaluation of the Tolerance, Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of MIL62 Injection for Treating Lupus Nephritis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2